PF
CMMB

Phoenix Financial’s Chemomab Therapeutics CMMB Stock Holding History

Phoenix Financial’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-408
Closed -$28K – 373
2020
Q3 		$28K Hold
408
– – ﹤0.01% 315
2020
Q2 		$34K Hold
408
– – ﹤0.01% 306
2020
Q1 		$20K Hold
408
– – ﹤0.01% 300
2019
Q4 		$36K Hold
408
– – ﹤0.01% 196
2019
Q3 		$57K Buy
+408
New +$79.3K ﹤0.01% 189

Other funds holding CMMB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RC
RegentAtlantic Capital Morristown, New Jersey $3.34B AUM 14.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Phoenix Financial's CMMB Position: Q4 2020 in Review

Phoenix Financial sold out of Chemomab Therapeutics (CMMB) in Q4 2020, closing a stake of 408 shares — an estimated $28K sold.

Phoenix Financial first reported a position in CMMB in Q3 2019 and held it in 5 quarters. The position peaked at $57K in Q3 2019. 5 funds tracked by Wall St. Rank hold CMMB as of Q4 2020.

  • Phoenix Financial reported no remaining Chemomab Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Phoenix Financial sold 408 Chemomab Therapeutics shares in Q4 2020, an estimated $28K.
  • Phoenix Financial first reported a position in Chemomab Therapeutics in Q3 2019 and held it in 5 quarters.
  • Phoenix Financial's Chemomab Therapeutics position peaked at $57K in Q3 2019.
  • 5 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q4 2020.

Based on Phoenix Financial's 13F filing for Q4 2020, filed 11 Feb 2021.